CohBar (CWBR) Competitors $0.50 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends CWBR vs. NOVN, PPBT, HOTH, BMRA, UPXI, AEZS, ORGS, HURA, ONVO, and ALZNShould you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Novan (NOVN), Purple Biotech (PPBT), Hoth Therapeutics (HOTH), Biomerica (BMRA), Upexi (UPXI), Aeterna Zentaris (AEZS), Orgenesis (ORGS), TuHURA Biosciences (HURA), Organovo (ONVO), and Alzamend Neuro (ALZN). CohBar vs. Novan Purple Biotech Hoth Therapeutics Biomerica Upexi Aeterna Zentaris Orgenesis TuHURA Biosciences Organovo Alzamend Neuro Novan (NASDAQ:NOVN) and CohBar (NASDAQ:CWBR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, valuation, community ranking, profitability, analyst recommendations, risk, dividends and earnings. Do institutionals and insiders hold more shares of NOVN or CWBR? 14.5% of Novan shares are held by institutional investors. Comparatively, 2.5% of CohBar shares are held by institutional investors. 1.3% of Novan shares are held by company insiders. Comparatively, 6.5% of CohBar shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is NOVN or CWBR more profitable? CohBar has a net margin of 0.00% compared to Novan's net margin of -128.61%. CohBar's return on equity of 0.00% beat Novan's return on equity.Company Net Margins Return on Equity Return on Assets Novan-128.61% -700.28% -39.58% CohBar N/A N/A N/A Does the MarketBeat Community favor NOVN or CWBR? Novan received 221 more outperform votes than CohBar when rated by MarketBeat users. However, 72.00% of users gave CohBar an outperform vote while only 53.11% of users gave Novan an outperform vote. CompanyUnderperformOutperformNovanOutperform Votes23953.11% Underperform Votes21146.89% CohBarOutperform Votes1872.00% Underperform Votes728.00% Which has more risk and volatility, NOVN or CWBR? Novan has a beta of -0.06, meaning that its stock price is 106% less volatile than the S&P 500. Comparatively, CohBar has a beta of 1.37, meaning that its stock price is 37% more volatile than the S&P 500. Which has stronger earnings and valuation, NOVN or CWBR? CohBar has lower revenue, but higher earnings than Novan. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNovan$24.71M0.00-$31.31M-$1.32N/ACohBarN/AN/A-$12.18MN/AN/A Does the media prefer NOVN or CWBR? In the previous week, Novan's average media sentiment score of 0.00 equaled CohBar'saverage media sentiment score. Company Overall Sentiment Novan Neutral CohBar Neutral SummaryCohBar beats Novan on 7 of the 10 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get CohBar News Delivered to You Automatically Sign up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CWBR vs. The Competition Export to ExcelMetricCohBarPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.46M$6.58B$5.10B$8.88BDividend YieldN/A8.11%5.02%4.07%P/E RatioN/A10.30131.9117.40Price / SalesN/A362.861,212.5785.49Price / CashN/A52.5939.3836.27Price / Book0.0910.176.906.36Net Income-$12.18M$153.60M$118.88M$225.88M7 Day Performance2.04%2.65%1.00%1.83%1 Month Performance2.04%-9.38%-4.20%1.65%1 Year Performance-44.44%28.29%30.91%26.68% CohBar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CWBRCohBarN/A$0.50flatN/A-44.2%$1.46MN/A0.0010NOVNNovanN/AN/AN/AN/A$2.64M$24.71M-0.0790Gap UpHigh Trading VolumePPBTPurple Biotech1.8041 of 5 stars$2.54+2.8%$33.00+1,199.2%N/A$3.38MN/A-0.2920HOTHHoth Therapeutics2.4675 of 5 stars$0.84+1.2%$3.50+319.2%-21.2%$5.76MN/A-0.634BMRABiomerica0.2098 of 5 stars$0.34+3.1%N/A-60.3%$5.46M$5.51M-0.9160News CoverageGap DownUPXIUpexi1.4374 of 5 stars$5.14+16.8%$25.00+386.4%-73.2%$5.35M$80.68M0.00130AEZSAeterna ZentarisN/A$2.98-0.7%N/A-56.2%$5.35M$2.37M-0.2020ORGSOrgenesis1.7492 of 5 stars$1.10+0.9%N/AN/A$5.28M$530,000.000.00150Gap DownHURATuHURA Biosciences0.9667 of 5 stars$3.37+2.4%$15.00+345.1%N/A$5.24MN/A0.00N/ANegative NewsGap UpONVOOrganovo0.682 of 5 stars$0.34-2.9%N/A-73.0%$5.23M$110,000.00-0.3320Analyst ForecastALZNAlzamend Neuro1.6165 of 5 stars$1.30-0.8%$35.00+2,592.3%-88.1%$5.06MN/A0.004 Related Companies and Tools Related Companies Novan Alternatives Purple Biotech Alternatives Hoth Therapeutics Alternatives Biomerica Alternatives Upexi Alternatives Aeterna Zentaris Alternatives Orgenesis Alternatives TuHURA Biosciences Alternatives Organovo Alternatives Alzamend Neuro Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CWBR) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredBREAKING: NVDA loses $175 billion in 8 minutesIt's a wild week for the legendary chipmaker. Nvidia just beat earnings expectations across every metric, w...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CohBar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.